Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RWJ333369 adjunctive therapy for partial-onset seizures
2006-003941-17Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing RWJ333369 adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Percent reduction in seizure frequency. Started Sep 2006; status: completed.
02
Drugs
carisbamate
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2006-003941-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003941-17.